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A flexible and versatile synthetic approach for the 
construction of water-stable DNA-binding chiral peptide 
helicates and that is based in the solid phase peptide synthesis 
(SPPS) methodology is reported. 
The development of non-natural agents that can reproduce the 
DNA recognition properties of natural transcription factors 
remains a major goal in biological chemistry,1 as they might 
have a great impact in fundamental and applied biological 
research, and even lead to the development of gene-targeted 
therapies.2 Most of the efforts in this area have been directed 
towards the development of small organic binders, but in the 
past few years there has been a growing interest in the use of 
coordination and metallo-supramolecular compounds with 
unique structural and spectroscopic properties.3 
 Helicates have shown promising and unusual DNA-binding 
properties,4 including major groove binding,5 and recognition of 
DNA three-way junctions.6 However, nearly 20 years after the 
pioneering studies by Prof. Jean-Marie Lehn,7 helicates are still 
not viable alternatives to traditional DNA-binding agents. The 
slow development in the biological chemistry of metal helicates 
ultimately derives from the lack of efficient and versatile 
methodologies for their enantioselective synthesis,8 which 
usually result in mixtures of isomers of difficult separation,9 
insoluble or unstable species in water,10 and above all, lack of 
versatility for structural and functional optimization.11 Prof. 
Scott recently proposed a new synthetic approach to DNA-
binding helicates based in the self-assembly of aldehydes and 
amines in the presence of M(II) ions that allows the formation 
of water-stable and optically pure helicates.12 Although this 
method represents a great improvement over the traditional 
routes, it does not guarantee the straightforward access to 
structural variants to efficiently study the chemical and 
functional space. 
 Given our experience in the study of DNA recognition 
agents,13 DNA-binding peptides,14 metallopeptides,15 and 
helicates,10 we decided to investigate into this problem by 
developing an alternative approach to DNA–binding chiral 
helicates. Herein we report our proposal, which potentially 
combines the biocompatibility, modularity and structural 
control of peptides with the synthetic flexibility and versatility 
of solid-phase peptide synthesis (SPPS) methodology, which 
allows the straightforward construction and modification of the 
helicates and, therefore, the easy optimization of their 
biophysical properties. 
 2,2’-bipyridine (Bpy) is a privileged chelator that leads to 
stable complexes with many metal ions that has been 
extensively used in coordination and supramolecular 
chemistry.16 Thus, we decided to synthesize a Bpy analog 
appropriately modified for its application in SPPS as the basic 
component of our peptide helicates. Hence, the Bpy unit was 
derivatized with 5-amino-3-oxapentanoic acid (O1Pen) as a 
Fmoc-protected achiral amino acid (Fmoc-O1PenBpy-OH, 1, 
Scheme 1).15  
 Following the synthesis of the amino acid building block, 
we designed a peptidic ligand capable of folding into a single-
stranded dinuclear hairpin helicate; the selected peptide 
sequence contains six O1PenBpy units, which satisfy the 
coordination requirements of two octahedral metal centers, 
arranged in three sets (or substrands) of two consecutive Bpy 
residues connected through two short loops. The loops, whose 
structures have been previously optimized,15b are key 
components of this design, as they include a β-turn promoting -
[(D/L)-Pro]-Gly- sequence that preorganize the ligand and 
induce the folding of the peptidic chain into discrete dinuclear 
species, thus avoiding the formation of higher order and 
polymeric complexes in the presence of metal ions (Scheme 1).  
 In order to gain some information about the structural 
viability of our design, molecular modeling was performed on 
the Fe(II) helicate derived from the peptide ligand LL-H 
(Scheme 1). The system was optimized following a hierarchical 
protocol that consists in: 1) Molecular Dynamics simulation on 
the loops of the metalopeptide; 2) clustering of the resulting 
MD, and 3) refinement by QM/MM geometry minimization of 
the most populated cluster representatives (see ESI). The final 
calculation was performed with solvent and electronic 
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embedding effects. The lowest energy model presents a helical 
geometry (Scheme 1) with both Fe(II) ions in octahedral 
configurations and the six bipyridine rings ordered around the 
metal centers. The first coordination sphere of the metal ions is 
barely constrained by the entire peptide framework, indicating 
that an excellent complementarity between organic and 
inorganic moieties is achieved in this design.  
 
 
Scheme 1. Solid phase peptide synthesis of the peptide ligands LL-H and DD-H. 
Introducing of L-Pro or D-Pro residues in the loops selects a particular 
supramolecular chirality in the final helicates (ΛΛ- or ΔΔ-, respectively). Below, 
molecular representation of the most stable ΛΛ–[Fe2(LL-H)]4+ helicate 
highlighting the interaction of the ammonium group of the N-terminal end with 
the C-terminal loop. 
 Supported by the computational results, we synthesized the 
two enantiomeric peptide ligands, each of them equipped with 
two L-Pro (LL-H) or D-Pro residues (DD-H) in their loops 
(Scheme 1). Both peptidic strands were obtained following 
standard Fmoc/tBu solid-phase protocols,17 and purified by 
reverse-phase HPLC (see ESI). Incubation of 4.0 µM solutions 
of LL-H and DD-H in PBS buffer (pH = 5.1, 298 K) with 
increasing concentrations of Fe(II) resulted in a bathochromic 
shift of the bipyridine absorption band from 304 to 322 nm, as 
well as in the appearance of a new band centered at 545 nm, 
typical of octahedral trisbipyridine Fe(II) complexes (see ESI). 
The increase in the absorption intensity of the d-d band was 
used to calculate the binding constants, which were the same 
within the experimental error for both LL-H and DD-H,18 thus for 
the first association β1,1(LL-H) ≈ β1,1(DD-H) ≈ 12.9 µM, and the 
overall formation constants β2,1(LL-H) ≈ β2,1(DD-H) ≈ 18.9 
µM.19,20 The successful assembly of the helicate, which can be 
considered as quantitative, was further confirmed by MALDI-
TOF mass spectrometry showing a major peak at 2337.9 (see 
ESI). To our knowledge, SPPS has never been used for the 
preparation of helicates. Moreover, fully-peptide ligands have 
not been used before as precursors of metal helicates, and there 
are only a handful of examples of organic strands equipped 
with oligopeptides as spacers or functional appendages.21 
 
Figure 1. CD spectra of LL-H and DD-H peptide ligands (50 µM) and their 
corresponding helicates. LL-H before (black dashed line) and after (black solid 
line, ΛΛ–[Fe2(LL-H)]4+) addition of 2 eq. of Fe(II) and DD-H before (red dashed line) 
and after (red solid line, ΔΔ–[Fe2(DD-H)]4+) addition of 2 eq. of Fe(II). All 
measurements were made in PBS buffer pH = 7.4, 298 K. 
 As expected, LL-H and its enantiomer DD-H give rise to 
mirror image CD spectra with two bands of opposite signs at 
approximately 290 and 324 nm with a crossover at 303 nm 
(Figure 1 and ESI). The intensity of these bands decreases upon 
addition of Fe(II), while at the same time they display a 
bathochromic shift to 302 and 333 nm, respectively. The sign of 
the Cotton effect of the helicates is consistent with a Λ- 
configuration on each metal center for the LL-H derivative 
(ΛΛ-[Fe2(LL-H)]4+), and a Δ- configuration for the DD-H 
analog (ΔΔ-[Fe2(DD-H)]4+).22 These data confirm that the 
enantiomeric peptide ligands give rise to the enantiomeric 
helicates.23 This means that the chiral proline residues do not 
only direct the folding of the peptide chain into a discrete 
dinuclear helicate, but also encode its chirality, which is 
selected under thermodynamic control at room temperature in 
water media upon incubation with Fe(II) ions. Controlling the 
metal center configuration in helicates usually requires 
demanding synthetic procedures for obtaining chiral organic 
ligands,24 which complicates the access to multiple structural 
variants that are required for the systematic studies involved in 
the optimization of their biological properties. In our approach, 
however, the chirality of the peptide helicates arises naturally 
from two single Pro residues located in the loops connecting the 
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 The chiral peptide helicates seem to be very stable in water 
at room temperature, as no degradation or racemization 
processes were detected for several weeks. We also performed 
thermal denaturation experiments in which the changes in 
absorbance at 525 nm were monitored upon increasing the 
temperature from 20 to 100 ºC. The sigmoidal melting profiles 
observed for both helicates were consistent with cooperative 
transitions in the decomplexation of the Fe(II) ions (Figure 2, 
and ESI). Both melting curves were qualitatively similar; with a 
Tm temperature of ≈ 80.5 ºC. Van’t Hoff analysis of the thermal 
denaturation afforded the enthalpic and entropic changes of the 
unfolding process. As expected, the unfolding process of the 
helicate displays a positive entropic variation (∆S ≈ 447.1 
J/mol), consistent with the increase in molecular disorder 
resulting from the disassembly of the complexes; the unfolding 
process is also highly endothermic (∆H ≈ 157.9 kJ/mol), in 
agreement with the large association constants obtained in the 
UV/Vis titrations and reported studies of related 
supramolecular metal complexes.25 Alternatively, global 
analysis of the unfolding process using the Gibbs-Helmholtz 
equation provided qualitatively similar results.26 
 
Figure 2.  Left: Thermal denaturation curve and Van’t Hoff analysis of the 
thermal denaturation process of a 7 µM solution of ΛΛ–[Fe2(LL-H)]4+ in PBS buffer 
10 mM, NaCl 10 mM, pH 7.2. Black points represent the data near the transition 
used in the Van’t Hoff plot shown in the inset.  
 Having at hand the methodology for the efficient assembly 
of water-stable and optically pure peptide helicates, we decided 
to explore the DNA binding properties of these species. In 
particular, we were interested in studying the affinity and chiral 
selectivity of their binding to three-way DNA junction,27 data 
that remain unknown until now.  
 Towards this end, we synthesized the N-terminal rhodamine 
labeled derivatives of the previously described LL-H and DD-H 
peptide ligands. In short, once the core peptide sequences were 
fully assembled, and still attached to the solid support, their N-
terminal amines were reacted with 5-(and 6)-carboxy-X-
rhodamine succinimidyl ester to yield the fluorescent peptidic 
ligands LL-RhH and DD-RhH, which were then cleaved from 
the resin and purified as described before, and incubated with 2 
eq. of Fe(II) to form the corresponding fluorescent helicates 
ΛΛ–[Fe2(LL-RhH)]4+ and ΔΔ–[Fe2(DD-RhH)]4+ (Scheme 2). 
 
Scheme 2. Solid phase peptide synthesis of the Rhodamine-labeled peptide 
ligands LL-RhoH and DD-RhoH by solid phase modification of the core peptides, 
and their corresponding helicates (ΛΛ–[Fe2(LL-RhoH)]4+ or ΔΔ–[Fe2(DD-RhoH)]4+ 
respectively). See Scheme 1 for complete sequences of LL-H and DD-H. 
 Incubation of 1 µM solutions of the rhodamine-labeled 
helicates with increasing concentrations of the DNA three-way 
junction Y1Y2Y3 (see ESI) produced a concentration-dependent 
increase in the fluorescence anisotropy that could be fitted to a 
modified 1:1 binding mode, including higher order aggregates 
resulting from non-specific interactions (Figure 3).14 The ΛΛ–
[Fe2(LL-RhH)]4+ peptide helicate displayed significantly higher 
affinity—almost 150 fold—for the Y1Y2Y3 DNA junction than 
the enantiomeric ΔΔ–[Fe2(DD-RhH)]4+, with apparent 
dissociation constants for the 1:1 complexes of 0.25 ± 0.04 µM 
and 37.6 ± 1.0 µM, respectively.28 
  
Figure 3. Fluorescence anisotropy titrations of 1 µM solutions of peptidic 
helicates with a DNA three-way junction (Y1Y2Y3) in 10 mM phosphate buffer, 
NaCl 10 mM; pH: 7.3, 20 ºC. ΛΛ–[Fe2(LL-RhH)]4+ (left) and ΔΔ–[Fe2(DD-RhH)]4+ 
(right). Lines represent the best fit to 1:1 binding models including the 
contribution of nonspecific electrostatic complexes. DNA oligo sequences: Y1: 5’–
CAC CGC TCT GGT CCT C–3’; Y2: 5’–CAG GCT GTG AGC GGT G–3’; Y3: 5’–GAG GAC 
CAA CAG CCT G–3’. 
 In summary, herein we present a simple and versatile 
methodology for the enantioselective assembly of water-stable 
and DNA-binding helicates. This novel approach relies in the 
modularity and synthetic flexibility of solid-phase peptide 
synthesis and in the preorganization of the peptide ligand 
provided by two single proline residues, which also encode the 
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helical chirality of their corresponding helicates formed under 
thermodynamic control in water media in the presence of Fe(II) 
ions. We have demonstrated the potential of this approach 
synthesizing fluorescently-labeled helicates that show chiral 
discrimination and high selectivity for three-way DNA 
junctions. 
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